Title | A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) (ZUMA-1) |
---|---|
Disease/Condition | Blood and Bone Marrow Cancer |
Eligibility Criteria | Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements |
Principal Investigator | Ira Braunschweig, MD |
Contact Name | Karen Fehn |
Phone | (718) 405-8446 |
Contact Email | CPDMUtrialinfo@montefiore.org |
IRB/Protocol Number | IRB# 15-11-37-01 |
Status | Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |